MedTrace Logo

Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)

NCT03004950 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 922

Last updated 2023-10-23

No results posted yet for this study

Summary

This study is an observational non-interventional study which will examine a) the accuracy of biomarkers in predicting renal and cardiovascular outcomes after contrast-induced acute kidney injury.

This study will obtain de-identified human plasma \& urine samples and corresponding de-identified research study data on subjects who are enrolled into the Prevention of Serious Adverse Events Following Angiography (PRESERVE) study and Biomarker Collection and Analysis in the PRESERVE Trial (VA CSP #578). Biomarker analyses will be performed on the de-identified samples and merged with de-identified research study data.

Conditions

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • US Department of Veterans Affairs

    collaborator FED

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Raghavan Murugan, MD, MS, FRCP · University of Pittsburgh

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2022-02-28
Completion
2023-06-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03004950 on ClinicalTrials.gov